BUZZBERGThe leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it.Read the FAQ
Hyundai Motor is undervalued and in the early stage of a revaluation cycle, with significant long-term upside due to its controlling stake (80%+) in Boston Dynamics, its transformation into a physical AI and robotics company leveraging massive manufacturing capacity, data center investments, and strategic partnerships with Google and Nvidia. The stock is not expensive and offers growth potential beyond traditional auto sector valuation.
FCBGA substrates are experiencing a structural super-cycle driven by surging AI chip demand, TSMC's advanced packaging technologies (SoIC, CoWoS), and the need for larger, multi-layer, rigid substrates to eliminate GPU bottlenecks. This cycle is expected to last longer than the HBM cycle, and domestic producers Samsung Electro-Mechanics and Daeduck Electronics are ramping capacity to meet insatiable demand, leading to price increases and sustained revenue growth.
FCBGA substrates are experiencing a structural super-cycle driven by surging AI chip demand, TSMC's advanced packaging technologies (SoIC, CoWoS), and the need for larger, multi-layer, rigid substrates to eliminate GPU bottlenecks. This cycle is expected to last longer than the HBM cycle, and domestic producers Samsung Electro-Mechanics and Daeduck Electronics are ramping capacity to meet insatiable demand, leading to price increases and sustained revenue growth.
Hyundai Mobis is a key supplier of actuators for Boston Dynamics' Atlas robot, providing 31 out of 50 actuators per unit and accounting for about 60% of the robot's cost. This positions Mobis as a direct and high-margin beneficiary of the robotics mega-trend and the broader Hyundai Motor Group ecosystem.
SK Hynix will see earnings recovery as its contract pricing for HBM normalizes, and though it may lose some HBM market share to Samsung, absolute HBM volume growth and rising DRAM prices will drive profit improvement.
Samsung Electronics will gain HBM4 market share due to improved yields on a lower process node, leading to incremental earnings growth, while the overall strong semiconductor demand cycle continues until at least year-end with supply constraints lasting into Q2 2025.
In Korean biotech, focus on platform technology companies that export their technology rather than drug developers; specific names include Alteogen, Olix, and Alginomics, which have platform technologies and are safer bets.
In Korean biotech, focus on platform technology companies that export their technology rather than drug developers; specific names include Alteogen, Olix, and Alginomics, which have platform technologies and are safer bets.
In Korean biotech, focus on platform technology companies that export their technology rather than drug developers; specific names include Alteogen, Olix, and Alginomics, which have platform technologies and are safer bets.
US midterm election history shows a typical market decline in Q3 before the election, followed by a strong rally afterward; investors should use any pullback in the S&P 500 during Q3 2026 as a buying opportunity.
Kim Tae-hong has 10 trade ideas tracked on Buzzberg across 10 tickers since May 2026. Ranked #1077 on the Buzzberg Alpha leaderboard. Most covered: SPY, 000660.KS, 005930.KS.
#1077Ranked Speaker
#1077 of 1540 voices on Buzzberg